Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson’s Disease

por Hepp, Dagmar H., van Wageningen, Thecla A., Kuiper, Kirsten L., van Dijk, Karin D., Oosterveld, Linda P., Berendse, Henk W., van de Berg, Wilma D. J.
Publicado 2023

CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls

por Oosterveld, Linda P., Verberk, Inge M.W., Majbour, Nour K., El‐Agnaf, Omar M., Weinstein, Henry C., Berendse, Henk W., Teunissen, Charlotte E., van de Berg, Wilma D.J.
Publicado 2019

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies

por Chatterjee, Madhurima, van Steenoven, Inger, Huisman, Evelien, Oosterveld, Linda, Berendse, Henk, van der Flier, Wiesje M., Del Campo, Marta, Lemstra, Afina W., van de Berg, Wilma D. J., Teunissen, Charlotte E.
Publicado 2020

CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson′s Disease

por Oosterveld, Linda P., Kuiper, Tessa I., Majbour, Nour K., Verberk, Inge M. W., van Dijk, Karin D., Twisk, Jos W. R., El-Agnaf, Omar M., Teunissen, Charlotte E., Weinstein, Henry C., Klein, Martin, Berendse, Henk W., van de Berg, Wilma D. J.
Publicado 2020